TB-500 (Thymosin β4 fragment)

TB-500: Names, Spellings and What Each Finds

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides1 min readLast reviewed 2026-08-233 cited sources

The short answer

TB-500, TB500 and TB 500 are the same code. Thymosin beta-4, Tβ4 and beta-thymosins refer to the parent protein family. LKKTETQ names the motif. Which term you search determines whether you find research literature or commercial listings.

Key facts

Code variants
TB-500, TB500, TB 500
Parent protein
Thymosin beta-4, Tβ4, thymosin β4
Family
Beta-thymosins
Motif
LKKTETQ
Finds research
Thymosin beta-4, LKKTETQ
Finds listings
TB-500

The Greek letter problem

Thymosin β4 is frequently written with the Greek beta, and equally frequently transliterated as beta-4, b4 or B4. Databases and search engines handle these inconsistently, so a search using one form can miss records using another. Trying both the Greek and the transliterated form is worth the extra query.

Hyphenation

TB-500, TB500 and TB 500 are used interchangeably with no distinction whatever. Similarly thymosin beta-4, thymosin beta 4 and thymosin-beta-4. None of these variations signals anything about the compound; they are typographic preferences.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

Which term returns what

Searching TB-500 returns predominantly commercial and forum content, because researchers do not use the code. Searching thymosin beta-4 returns the scientific literature. Searching LKKTETQ returns work specifically on the motif, which is the narrowest and most fragment-relevant set. The three searches produce strikingly different pictures of the same subject.

Descriptive names in circulation

Thymosin Beta-4 Fragment and Ac-LKKTETQ both appear on supplier documentation. The second is the most informative, since it states the actual sequence and the acetylation rather than describing a relationship to a parent.

Why this matters more here than usual

Because the naming ambiguity tracks a real chemical ambiguity. When one name covers both a 889 Da heptapeptide and a 4,963 Da protein, imprecise naming is not a cosmetic issue. It is the mechanism by which the two get confused. Preferring the sequence over the code is the simplest available fix.

Frequently asked questions

Is TB500 different from TB-500?
No. Hyphenation and spacing vary freely and signal nothing about the compound.
Why do searches for TB-500 and thymosin beta-4 differ so much?
TB-500 is a market-side code; researchers publish under thymosin beta-4. The two terms reach different bodies of content.
What is the most precise name?
Ac-LKKTETQ, which states the sequence and the acetylation rather than a relationship to a parent protein.

Extended research context

The TB-500 (Thymosin β4 fragment) deep dive

Deep dive: TB-500 vs full-length Thymosin Beta-4

'TB-500' is a synthetic peptide corresponding to the active 17-amino-acid actin-binding region of the endogenous 43-residue Thymosin Beta-4 protein. The two are not identical. TB-500 lacks the flanking sequence that gives full-length TB-4 additional binding partners. In the research literature, papers use 'Thymosin β4' when they mean the full protein and 'TB-500' or 'AcSDKP fragment' when they mean the shorter synthetic peptide. Reading a CoA carefully to see which molecule is in the vial matters. Mass spec is the definitive check.

Actin-binding as the core mechanism

The N-terminal region of TB-4 (and TB-500 by inheritance) contains the canonical actin-binding motif. This motif sequesters G-actin monomers, modulating the G:F actin equilibrium in cell cultures. That mechanism is why almost every mechanistic paper on TB-500 traces back to cytoskeletal reorganisation, cell migration, and models of tissue repair.

Handling considerations unique to TB-500

TB-500 is a 17-residue peptide with modest amphipathicity; it reconstitutes cleanly in bacteriostatic water but is sensitive to repeated freeze/thaw. Aliquoting into single-use volumes on first reconstitution preserves potency across a batch. HPLC on the batch CoA should show a single dominant peak; a doublet suggests deamidation.

Research applications

  • ▸In vitro actin-polymerisation assays (G:F actin ratio measurement)
  • ▸Cell-migration and wound-scratch assays in fibroblast lines
  • ▸Angiogenesis models: tube-formation and endothelial migration assays
  • ▸Analytical method development for short peptides on RP-HPLC
  • ▸Reference-material comparisons against endogenous Thymosin β4

Handling checklist

  • ✓Store lyophilised vials at −20 °C long-term
  • ✓Reconstitute with bacteriostatic water (0.9% benzyl alcohol)
  • ✓Aliquot immediately to avoid freeze/thaw cycles
  • ✓Refrigerate reconstituted aliquots at 2–8 °C; use within 28 days
  • ✓Confirm mass (~4,963 Da for TB-500) via CoA before study use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Assuming TB-500 = full Thymosin β4

Fix: TB-500 is the 17-residue actin-binding fragment; check the CoA sequence.

✗ Repeated freeze/thaw

Fix: Aliquot at first reconstitution; each cycle degrades yield.

✗ Using tap water

Fix: Use bacteriostatic or sterile water only.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More TB-500 (Thymosin β4 fragment) articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.